quinone methide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jaouen, G; McGlinchey, MJ; Pigeon, P; Top, S; Wang, Y | 1 |
1 other study(ies) available for quinone methide and ER-Negative PR-Negative HER2-Negative Breast Cancer
Article | Year |
---|---|
Organometallic Antitumor Compounds: Ferrocifens as Precursors to Quinone Methides.
Topics: Cell Proliferation; Chromatography, High Pressure Liquid; Cyclization; Ferrous Compounds; Hep G2 Cells; Humans; Indolequinones; Organometallic Compounds; Oxidation-Reduction; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2015 |